On November 22, 2004, the diabetes business unit of Medtronic, Inc., and Novo Nordisk announced an agreement to develop the first prefilled cartridges designed for use with Paradigm external insulin pumps.
According to the two companies, “Prefilled cartridges containing NovoLog are expected to offer a convenient option for people using Paradigm pump therapy.”
In addition to developing the prefilled cartridges, the companies intend to start clinical studies to demonstrate the advantages of NovoLog insulin and Paradigm pump therapy over other insulin therapies.
* * *
Sources: Novo Nordisk and Medtronic MiniMed